V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10268168 | 10064087 | 1.67 | 103 | Palliative (P) | 2019-04-19 | 2019-07-25 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100216400 |
| 10268449 | 10064089 | 1.68 | 55 | 03 | 2019-07-03 | 2019-07-03 | Radium 223 | 02 | N | CARBOPLATIN | 100198513 |
| 10268829 | 10064091 | 1.75 | 136 | Palliative (P) | 2017-07-23 | 2017-07-24 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100776240 |
| 10268863 | 10064092 | 1.54 | 61.6 | Adjuvant (A) | 2019-10-19 | 2020-03-08 | Bortezomib + Daratumumab | 02 | N | BORTEZOMIB + DARATUMUMAB | 100041984 |
| 10269000 | 10064094 | 1.83 | 90 | null | 2019-02-14 | 2019-10-04 | null | null | null | POMALIDOMIDE | 100219818 |
| 10269188 | 10064096 | 1.6 | 91.1 | null | 2020-04-15 | 2022-02-10 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100319326 |
| 10269418 | 10064099 | 1.8 | 123 | null | 2019-11-24 | 2019-11-24 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101566044 |
| 10270153 | 10064109 | 1.68 | 91 | null | 2016-12-07 | 2017-01-15 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101643076 |
| 10270196 | 10064110 | 1.87 | 55.1 | Palliative (P) | 2018-05-10 | 2018-05-10 | null | 02 | N | CARBOPLATIN | 100248763 |
| 10270367 | 10064112 | 1.79 | 39 | null | 2019-04-27 | 2019-09-06 | IMATINIB | 02 | null | IMATINIB | 101060306 |
| 10270389 | 10064113 | null | null | null | 2018-12-21 | 2018-12-21 | Radium 223 | 02 | null | CARBOPLATIN + ETOPOSIDE | 100427983 |
| 10270451 | 10064114 | 1.62 | 55.1 | null | 2018-10-22 | 2018-10-22 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100432621 |
| 10270532 | 10064115 | 1.68 | 118 | Palliative (P) | 2019-06-07 | 2019-06-26 | Bortezomib + Daratumumab | null | N | BORTEZOMIB + DARATUMUMAB | 100239414 |
| 10270563 | 10064116 | 1.61 | 64.1 | null | 2017-01-03 | 2017-01-04 | null | 02 | null | BACILLUS CALMETTE-GUERIN | 101157955 |
| 10270644 | 10064118 | 1.6 | 57.8 | null | 2014-02-19 | 2017-08-22 | null | null | null | ATEZOLIZUMAB | 100647565 |
| 10270706 | 10064119 | 1.56 | 77.4 | Curative (C) | 2018-07-13 | 2018-07-19 | Bortezomib + Daratumumab | 02 | N | BORTEZOMIB + DARATUMUMAB | 100705458 |
| 10271083 | 10064120 | 1.74 | 84.1 | 03 | 2019-10-25 | 2019-11-21 | null | 2 | N | ATEZOLIZUMAB | 100970833 |
| 10271105 | 10064121 | 1.77 | 94.3 | null | 2017-11-03 | 2017-11-05 | null | null | null | CARBOPLATIN + PEMETREXED | 100341429 |
| 10271278 | 10064124 | 1.72 | 64 | Palliative (P) | 2017-06-30 | 2017-07-02 | null | 02 | N | CARBOPLATIN | 100325057 |
| 10271403 | 10064126 | 1.87 | 71.2 | Palliative (P) | 2018-09-03 | 2018-12-02 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101654040 |
| 10271414 | 10064127 | 1.66 | 54.1 | null | 2017-12-27 | 2017-12-27 | null | null | null | CARBOPLATIN | 100226813 |
| 10271535 | 10064130 | 1.81 | 100 | null | 2020-06-21 | 2020-08-25 | null | 02 | null | RITUXIMAB + VENETOCLAX | 100907694 |
| 10271583 | 10064131 | 1.7 | 0 | null | null | 2018-03-10 | null | 02 | null | IXAZOMIB + LENALIDOMIDE | 100659683 |
| 10271823 | 10064133 | 1.7 | 61.2 | Palliative (P) | 2017-03-31 | 2017-03-31 | null | 02 | Y | CARBOPLATIN + PEMETREXED | 100751536 |
| 10272225 | 10064137 | 1.62 | 0 | null | 2017-07-07 | 2018-05-16 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101124450 |
| 10272614 | 10064138 | null | null | Adjuvant (A) | 2018-10-17 | 2018-10-17 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101035638 |
| 10272894 | 10064140 | 1.77 | 63.2 | null | 2018-10-03 | 2018-10-03 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101475305 |
| 10272978 | 10064141 | 1.68 | 60.4 | null | null | 2019-08-06 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101552672 |
| 10273427 | 10064144 | null | null | Palliative (P) | 2017-12-18 | 2019-09-30 | null | 02 | N | POMALIDOMIDE | 100565312 |
| 10273873 | 10064147 | null | null | null | 2018-10-28 | 2018-10-28 | null | 02 | null | IXAZOMIB + LENALIDOMIDE | 100150202 |
| 10274077 | 10064149 | 1.64 | 58.3 | null | 2018-02-14 | 2018-06-12 | Radium 223 | 02 | null | IMATINIB | 100591567 |
| 10274788 | 10064155 | 1.9 | 0 | null | 2019-04-03 | 2019-04-17 | Bortezomib + Daratumumab | 02 | null | BORTEZOMIB + DARATUMUMAB | 101034551 |
| 10274853 | 10064156 | 1.83 | 44.5 | null | 2017-02-19 | 2017-02-19 | null | 02 | null | ATEZOLIZUMAB | 101171445 |
| 10274889 | 10064157 | null | null | null | 2019-04-15 | 2019-04-15 | null | null | null | IXAZOMIB + LENALIDOMIDE | 101244172 |
| 10275067 | 10064159 | 1.88 | 61.6 | Curative (C) | 2019-08-24 | 2019-08-24 | null | 02 | N | CARBOPLATIN | 101077171 |
| 10275129 | 10064160 | 1.76 | 86 | null | 2019-06-24 | 2019-06-30 | null | 02 | null | POMALIDOMIDE | 100786606 |
| 10275332 | 10064161 | 1.52 | 76.2 | null | 2016-11-03 | 2017-10-07 | null | 02 | null | BORTEZOMIB + DARATUMUMAB | 100280926 |
| 10275669 | 10064162 | 1.65 | 79 | Adjuvant (A) | 2019-06-20 | 2019-06-24 | Ixazomib + Lenalidomide | 02 | N | IXAZOMIB + LENALIDOMIDE | 100018890 |
| 10275978 | 10064165 | 1.78 | 78 | null | 2019-12-02 | 2019-12-14 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101609851 |
| 10276087 | 10064166 | 1.74 | 96.9 | Palliative (P) | 2015-07-24 | 2017-04-20 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100960547 |
| 10276207 | 10064167 | 1.59 | 64.7 | null | 2018-01-31 | 2019-08-06 | Radium 223 | 02 | null | TEMOZOLOMIDE | 100139082 |
| 10279140 | 10064174 | 1.62 | 75.6 | Palliative (P) | null | 2020-01-25 | null | 02 | N | CARBOPLATIN + PEMETREXED | 101218218 |
| 10279170 | 10064175 | 1.65 | 68.6 | 03 | 2019-07-23 | 2019-09-12 | Carboplatin + Pemetrexed | 02 | N | CARBOPLATIN + PEMETREXED | 100069346 |
| 10279408 | 10064176 | 0 | 69.1 | null | 2016-06-08 | 2016-07-20 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100876226 |
| 10279447 | 10064177 | 0 | 67.2 | null | 2021-03-27 | 2021-08-29 | Bortezomib + Daratumumab | 02 | null | BORTEZOMIB + DARATUMUMAB | 100448039 |
| 10279528 | 10064178 | 1.6 | 0 | 03 | 2018-05-24 | 2018-07-02 | IMATINIB | 02 | N | IMATINIB | 100992674 |
| 10280301 | 10064180 | 1.77 | null | null | 2021-07-29 | 2022-04-15 | null | null | null | POMALIDOMIDE | 100683332 |
| 10280346 | 10064181 | 1.73 | 39 | Curative (C) | 2019-11-19 | 2019-11-25 | null | 02 | N | POMALIDOMIDE | 100732089 |
| 10281415 | 10064182 | 1.75 | 94 | 03 | 2020-01-13 | 2020-01-31 | null | 02 | N | RITUXIMAB + VENETOCLAX | 100945463 |
| 10281839 | 10064186 | 1.46 | 93.6 | null | 2020-01-28 | 2020-02-18 | Radium 223 | 02 | null | CARBOPLATIN | 100273133 |